Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$35.55 - $43.57 $590,449 - $723,654
-16,609 Reduced 9.0%
167,861 $7.32 Million
Q3 2023

Nov 08, 2023

SELL
$39.13 - $47.24 $136,407 - $164,678
-3,486 Reduced 1.85%
184,470 $7.32 Million
Q2 2023

Aug 03, 2023

SELL
$43.93 - $46.76 $35,802 - $38,109
-815 Reduced 0.43%
187,956 $8.32 Million
Q1 2023

May 05, 2023

SELL
$45.29 - $50.76 $206,160 - $231,059
-4,552 Reduced 2.35%
188,771 $8.61 Million
Q4 2022

Feb 09, 2023

BUY
$41.91 - $50.48 $7.26 Million - $8.75 Million
173,323 Added 866.62%
193,323 $9.7 Million
Q4 2022

Feb 08, 2023

BUY
$41.91 - $50.48 $672,320 - $809,800
16,042 Added 405.31%
20,000 $4.32 Million
Q3 2022

Nov 04, 2022

SELL
$40.9 - $50.42 $7.53 Million - $9.28 Million
-184,144 Reduced 97.9%
3,958 $163,000
Q2 2022

Aug 09, 2022

BUY
$42.98 - $49.77 $7.97 Million - $9.22 Million
185,344 Added 6720.23%
188,102 $8.78 Million
Q2 2022

Aug 08, 2022

SELL
$42.98 - $49.77 $7.84 Million - $9.08 Million
-182,456 Reduced 98.51%
2,758 $1.55 Million
Q1 2022

May 10, 2022

SELL
$42.23 - $54.3 $60.7 Million - $78.1 Million
-1,438,380 Reduced 88.59%
185,214 $9.29 Million
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $2.46 Million - $2.74 Million
-48,579 Reduced 2.91%
1,623,594 $90 Million
Q3 2021

Nov 10, 2021

BUY
$46.55 - $56.83 $5.85 Million - $7.14 Million
125,653 Added 8.12%
1,672,173 $86.7 Million
Q2 2021

Aug 05, 2021

BUY
$46.28 - $52.75 $20.2 Million - $23.1 Million
437,391 Added 39.44%
1,546,520 $76.1 Million
Q4 2020

Feb 09, 2021

BUY
$46.09 - $54.74 $51.1 Million - $60.7 Million
1,109,129 New
1,109,129 $58.6 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.16B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.